Amedeo Smart

Free Medical Literature Service


 

Amedeo

Inflammatory Bowel Diseases

  Free Subscription

Articles published in
Gastroenterology
    May 2024
  1. LUJAN R, Buchuk R, Focht G, Yogev D, et al
    Early Initiation of Biologics and Disease Outcomes in Adults and Children With Inflammatory Bowel Diseases: Results From the Epidemiology Group of the Nationwide Israeli Inflammatory Bowel Disease Research Nucleus Cohort.
    Gastroenterology. 2024;166:815-825.
    >> Share

  2. BAMIDELE AO, Mishra SK, Piovezani Ramos G, Hirsova P, et al
    Interleukin 21 Drives a Hypermetabolic State and CD4(+) T-Cell-Associated Pathogenicity in Chronic Intestinal Inflammation.
    Gastroenterology. 2024;166:826-841.
    >> Share

    April 2024
  3. HONAP S, Sands BE, Jairath V, Danese S, et al
    Basket, Umbrella, and Platform Trials: The Potential for Master Protocol -Based Trials in Inflammatory Bowel Disease.
    Gastroenterology. 2024 Apr 25:S0016-5085(24)00485.
    >> Share

  4. KEEFER L, Hashash JG, Szigethy E, Mayer EA, et al
    AGA Clinical Practice Update on Pain Management in Inflammatory Bowel Disease: Commentary.
    Gastroenterology. 2024 Apr 17:S0016-5085(24)00358.
    >> Share

  5. ZOLLNER A, Koch R, Jukic A, Pfister A, et al
    Clearance of gut mucosal SARS-CoV-2 antigens and post-acute COVID-19 after two years in patients with inflammatory bowel disease.
    Gastroenterology. 2024 Apr 15:S0016-5085(24)00423.
    >> Share

    March 2024
  6. IACUCCI M, Maeda Y, Ghosh S
    A Baby Step or a Real Giant Stride: Histomic Enabled by Artificial Intelligence to Predict Treatment Response in Pediatric Patients with Ulcerative Colitis.
    Gastroenterology. 2024 Mar 7:S0016-5085(24)00284.
    >> Share

  7. MITEV S, Marinova C, Spassova Z
    A colorful conundrum: dark urine in a patient with inflammatory bowel disease.
    Gastroenterology. 2024 Mar 5:S0016-5085(24)00249.
    >> Share

  8. PEERY AF, Kelly CR, Kao D, Vaughn BP, et al
    AGA Clinical Practice Guideline on Fecal Microbiota-Based Therapies for Select Gastrointestinal Diseases.
    Gastroenterology. 2024;166:409-434.
    >> Share

  9. DULAI PS, Singh S, Jairath V, Wong E, et al
    Integrating Evidence to Guide Use of Biologics and Small Molecules for Inflammatory Bowel Diseases.
    Gastroenterology. 2024;166:396-408.
    >> Share

    February 2024
  10. KHROM M, Long M, Dube S, Robbins L, et al
    Comprehensive association analyses of extraintestinal manifestations in inflammatory bowel disease.
    Gastroenterology. 2024 Feb 27:S0016-5085(24)00232.
    >> Share

  11. HERAUF M, Coward S, Pena-Sanchez JN, Bernstein CN, et al
    A Commentary on the Epidemiology of Inflammatory Bowel Disease in Compounding Prevalence Nations: Towards Sustaining Healthcare Delivery.
    Gastroenterology. 2024 Feb 18:S0016-5085(24)00178.
    >> Share

  12. MARILD K, Soderling J, Stephansson O, Axelrad J, et al
    Histological remission in inflammatory bowel disease and female fertility: A nationwide study.
    Gastroenterology. 2024 Feb 6:S0016-5085(24)00055.
    >> Share

  13. KOCHAR B, Ananthakrishnan AN, Ritchie CS
    Pharmacoequity for Older Adults With Inflammatory Bowel Diseases.
    Gastroenterology. 2024;166:235-239.
    >> Share

  14. HE S, Peng Y, Wei Q
    Comments on "Higher Intra-Abdominal Visceral Adipose Tissue Mass Is Associated With Lower Rates of Clinical and Endoscopic Remission in Patients With Inflammatory Bowel Diseases Initiating Biologic Therapy: Results of the Constellation Study".
    Gastroenterology. 2024;166:356-357.
    >> Share

  15. LIU X, Prasath S, Siddiqui I, Walters TD, et al
    Machine Learning-Based Prediction of Pediatric Ulcerative Colitis Treatment Response using Diagnostic Histopathology.
    Gastroenterology. 2024 Feb 1:S0016-5085(24)00119.
    >> Share

    January 2024
  16. HASHASH JG, Elkins J, Lewis JD, Binion DG, et al
    AGA Clinical Practice Update on Diet and Nutritional Therapies in Patients With Inflammatory Bowel Disease: Expert Review.
    Gastroenterology. 2024 Jan 23:S0016-5085(23)05597.
    >> Share

  17. KOSINSKY RL, Gonzalez MM, Saul D, Barros LL, et al
    The FOXP3(+) Pro-inflammatory T cell: A Potential Therapeutic Target in Crohn's Disease.
    Gastroenterology. 2024 Jan 9:S0016-5085(24)00009.
    >> Share

  18. BARNES EL, Agrawal M, Syal G, Ananthakrishnan AN, et al
    AGA Clinical Practice Guideline on the Management of Pouchitis and Inflammatory Pouch Disorders.
    Gastroenterology. 2024;166:59-85.
    >> Share

  19. GILLILAND A, Chan JJ, De Wolfe TJ, Yang H, et al
    Pathobionts in Inflammatory Bowel Disease: Origins, Underlying Mechanisms, and Implications for Clinical Care.
    Gastroenterology. 2024;166:44-58.
    >> Share

  20. EQUINOZZI E, O'Donnell M, Lee CD
    A Woman With Pyoderma Gangrenosum, Recurrent Abdominal Pain, and Hematochezia.
    Gastroenterology. 2024;166:31-35.
    >> Share

  21. SHEN X, Zhang Q, Zhang B
    A 16-Year-Old Onset Case of Pancolitis With Rectovaginal and Rectovesical Fistulas.
    Gastroenterology. 2024;166:e1-e5.
    >> Share

    December 2023
  22. CAENEPEEL C, Falony G, Machiels K, Verstockt B, et al
    Dysbiosis and associated stool features improve prediction of response to biological therapy in inflammatory bowel disease.
    Gastroenterology. 2023 Dec 12:S0016-5085(23)05598.
    >> Share

  23. ANANTHAKRISHNAN AN, Adler J, Chachu KA, Nguyen NH, et al
    AGA Clinical Practice Guideline on the Role of Biomarkers for the Management of Crohn's Disease.
    Gastroenterology. 2023;165:1367-1399.
    >> Share

  24. SEGAL JP
    Vedolizumab Earning Its Place as a Treatment for Chronic Pouchitis.
    Gastroenterology. 2023;165:1574-1575.
    >> Share

    November 2023
  25. KOTLARZ DANIEL
    Unveiling the protective role of BTNL-selected gammadelta T cells in inflammatory bowel disease.
    Gastroenterology. 2023 Nov 28:S0016-5085(23)05566.
    >> Share

  26. DAVE M, Luther J, Briggs F
    Time to Include Inflammatory Bowel Disease as a Notifiable Disease?
    Gastroenterology. 2023 Nov 7:S0016-5085(23)05223.
    >> Share

  27. WINE E
    Could gut and food-derived yeast be responsible for activating T-cells in Crohn disease?
    Gastroenterology. 2023 Nov 3:S0016-5085(23)05204.
    >> Share

  28. VENKATESWARAN N
    Mirikizumab for the Management of Ulcerative Colitis.
    Gastroenterology. 2023 Nov 3:S0016-5085(23)05206.
    >> Share

    October 2023
  29. LEE HH, Singh S
    Quantifying Endoscopic Activity in Ulcerative Colitis: Innovation, Powered by AI.
    Gastroenterology. 2023 Oct 30:S0016-5085(23)05201.
    >> Share

  30. STIDHAM RW, Cai L, Cheng S, Rajaei F, et al
    Using Computer Vision to Improve Endoscopic Disease Quantification in Therapeutic Clinical Trials of Ulcerative Colitis.
    Gastroenterology. 2023 Oct 11:S0016-5085(23)05086.
    >> Share

  31. YARUR AJ, Bruss A, Moosreiner A, Beniwal-Patel P, et al
    Higher Intra-Abdominal Visceral Adipose Tissue Mass Is Associated With Lower Rates of Clinical and Endoscopic Remission in Patients With Inflammatory Bowel Diseases Initiating Biologic Therapy: Results of the Constellation Study.
    Gastroenterology. 2023;165:963-975.
    >> Share

    September 2023
  32. CHEN J, Yang Q, Wang C
    Multiple Hepatic Masses in a Patient with Crohn's disease.
    Gastroenterology. 2023 Sep 20:S0016-5085(23)05014.
    >> Share

  33. KHANNA R
    Upadacitinib for the Treatment of Crohn's Disease.
    Gastroenterology. 2023 Sep 13:S0016-5085(23)05001.
    >> Share

  34. GANAPATHY A, Navale P, Mutch MG, Kim H, et al
    Long-Standing Symptomatic Fistulizing Perianal Crohn's Disease: Progression beyond inflammation.
    Gastroenterology. 2023 Sep 12:S0016-5085(23)04997.
    >> Share

  35. LI Z, Chen Y, Ke H
    Investigating the Causal Relationship between Gut Microbiota and Crohn's Disease: A Mendelian Randomization Study.
    Gastroenterology. 2023 Sep 5:S0016-5085(23)04972.
    >> Share

  36. HUANG J, Chan SC, Fung YC, Mak FY, et al
    Incidence, Risk Factors, and Temporal Trends of Small Intestinal Cancer: A Global Analysis of Cancer Registries.
    Gastroenterology. 2023;165:600-612.
    >> Share

  37. WINE E
    Pharmacomicrobiomics in IBD: Should We Select Treatments Based on Gut Microbes?
    Gastroenterology. 2023;165:802-803.
    >> Share

    August 2023
  38. PEYRIN-BIROULET L, Allegretti JR, Rubin DT, Bressler B, et al
    Guselkumab in Patients With Moderately to Severely Active Ulcerative Colitis: QUASAR Phase 2b Induction Study.
    Gastroenterology. 2023 Aug 31:S0016-5085(23)04963.
    >> Share

  39. LELEIKO NS
    Comment Regarding "Comparative Effectiveness of Anti-TNF in Combination With Low-Dose Methotrexate vs Anti-TNF Monotherapy in Pediatric Crohn's Disease: A Pragmatic Randomized Trial".
    Gastroenterology. 2023 Aug 7:S0016-5085(23)04882.
    >> Share

  40. KELM M, Flemming S
    Surgical Resection Might Be the Preferred Therapy Option in Ileocecal Crohn's Disease.
    Gastroenterology. 2023 Aug 4:S0016-5085(23)04840.
    >> Share

  41. DAMAS OM, Maldonado-Contreras A
    Breaking Barriers in Dietary Research: Strategies to Diversify Recruitment in Clinical Studies and Develop Culturally Tailored Diets for Hispanic Communities Living With Inflammatory Bowel Disease.
    Gastroenterology. 2023;165:324-328.
    >> Share

    July 2023
  42. MUKHERJEE PK, Nguyen QT, Li J, Zhao S, et al
    Stricturing Crohn's disease single-cell RNA sequencing reveals fibroblast heterogeneity and intercellular interactions.
    Gastroenterology. 2023 Jul 26:S0016-5085(23)04788.
    >> Share

  43. LEWIS JD, Parlett LE, Jonsson-Funk ML, Brensinger C, et al
    Incidence, Prevalence and Racial and Ethnic Distribution of Inflammatory Bowel Disease in the United States.
    Gastroenterology. 2023 Jul 15:S0016-5085(23)04776.
    >> Share

  44. BAUMDICK ME, Niehrs A, Degenhardt F, Schwerk M, et al
    HLA-DP on Epithelial Cells enables Tissue Damage by NKp44(+) NK Cells in Ulcerative Colitis.
    Gastroenterology. 2023 Jul 14:S0016-5085(23)04772.
    >> Share

  45. YAN F, Yang Y
    First line treatment options for ileocecal Crohn's disease: Early surgical resection or Biologics?
    Gastroenterology. 2023 Jul 3:S0016-5085(23)00933.
    >> Share

  46. DEEPAK P, Barnes EL, Shaukat A
    Health Disparities in Inflammatory Bowel Disease Care Driven by Rural Versus Urban Residence: Challenges and Potential Solutions.
    Gastroenterology. 2023;165:11-15.
    >> Share

  47. GHUSN W, Acosta A, Kane S
    An Unusual Etiology of Bleeding in an Inflammatory Bowel Disease Surveillance Colonoscopy.
    Gastroenterology. 2023;165:40-43.
    >> Share

    June 2023
  48. GAO S, Zhu R, Zhu L
    Toward the understanding of altered gut microbiome in Crohn's disease: cause or consequence.
    Gastroenterology. 2023 Jun 23:S0016-5085(23)00883.
    >> Share

  49. AGRAWAL M, Ebert AC, Poulsen G, Ungaro RC, et al
    Early ileocecal resection for Crohn's disease is associated with improved long-term outcomes compared to anti-tumor necrosis factor therapy: a population-based cohort study.
    Gastroenterology. 2023 Jun 9:S0016-5085(23)00872.
    >> Share

  50. HE S, Lei P, Kang W, Cheung P, et al
    Stiffness Restricts the Stemness of the Intestinal Stem Cells and Skews Their Differentiation Toward Goblet Cells.
    Gastroenterology. 2023;164:1137-1151.
    >> Share

  51. ROSHANOV PS, Khanna R
    Continuation of Tumor Necrosis Factor Antagonists for Inflammatory Bowel Diseases During Pregnancy.
    Gastroenterology. 2023;164:1336-1337.
    >> Share

  52. KILINCALP S, Mottacki N
    A Shallow Large Ulcer on the Ileocecal Valve in a Young Man With Ulcerative Proctitis.
    Gastroenterology. 2023;164:e16-e18.
    >> Share

    May 2023
  53. RAYGOZA GARAY JA, Turpin W, Lee SH, Smith MI, et al
    Gut Microbiome Composition is associated with future onset of Crohn's Disease in Healthy First-Degree Relatives.
    Gastroenterology. 2023 May 30:S0016-5085(23)00805.
    >> Share

  54. GHONEIM S
    Etrasimod in ulcerative colitis.
    Gastroenterology. 2023 May 11:S0016-5085(23)00725.
    >> Share

  55. ARMSTRONG H, Sigall-Boneh R, Wine E
    This Letter to the Editor is in response to: Microbial Riboflavin Biosynthesis Associates with Response to Dietary Fiber Consumption: Time to Personalize Adjunct Therapy in Patients with Inflammatory Bowel Disease?
    Gastroenterology. 2023 May 5:S0016-5085(23)00700.
    >> Share

  56. NEWMAN KL, Chedid VG, Boden EK
    A Systematic Review of Inflammatory Bowel Disease Epidemiology and Health Outcomes in Sexual and Gender Minority Individuals.
    Gastroenterology. 2023;164:866-871.
    >> Share

    April 2023
  57. NOBLE AJ, Nowak JK, Adams AT, Uhlig HH, et al
    Defining interactions between the genome, epigenome, and the environment in inflammatory bowel disease: progress and prospects.
    Gastroenterology. 2023 Apr 14:S0016-5085(23)00619.
    >> Share

  58. D'HAENS GR, Lee S, Taylor SA, Serone A, et al
    Filgotinib for the Treatment of Small Bowel Crohn's Disease: the DIVERGENCE 1 Trial.
    Gastroenterology. 2023 Apr 11:S0016-5085(23)00591.
    >> Share

  59. ALLEGRETTI JR, Mitsialis V, Canavan JB, Snapper SB, et al
    Low-dose IL-2 for the Treatment of Moderate to Severe Ulcerative Colitis.
    Gastroenterology. 2023 Apr 6:S0016-5085(23)00584.
    >> Share

  60. FRAISSENON A, Desmurs-Clavel H, Guibaud L
    Severe Chronic Rectocolitis Associated With a Characteristic Sunflower Magnetic Resonance Imaging Pattern.
    Gastroenterology. 2023;164:529-532.
    >> Share

  61. GOWEN R, Gamal A, Di Martino L, McCormick TS, et al
    Modulating the Microbiome for Crohn's Disease Treatment.
    Gastroenterology. 2023;164:828-840.
    >> Share

    March 2023
  62. KAPPELMAN MD, Wohl DA, Herfarth HH, Firestine AM, et al
    Comparative Effectiveness of Anti-TNF in Combination with Low Dose Methotrexate vs Anti-TNF Monotherapy in Pediatric Crohn's Disease: a Pragmatic Randomized Trial.
    Gastroenterology. 2023 Mar 31:S0016-5085(23)00538.
    >> Share

  63. YANG Z, Qin J, Zhao L, Chen T, et al
    Host sorbitol and bacterial sorbitol utilization promote C. difficile infection in inflammatory bowel disease.
    Gastroenterology. 2023 Mar 8:S0016-5085(23)00238.
    >> Share

  64. IACUCCI M, Parigi TL, Del Amor R, Meseguer P, et al
    Artificial Intelligence enabled histological prediction of remission or activity and clinical outcomes in ulcerative colitis.
    Gastroenterology. 2023 Mar 3:S0016-5085(23)00216.
    >> Share

  65. SINGH S, Ananthakrishnan AN, Nguyen NH, Cohen BL, et al
    AGA Clinical Practice Guideline on the Role of Biomarkers for the Management of Ulcerative Colitis.
    Gastroenterology. 2023;164:344-372.
    >> Share

  66. NOVIELLO D, Facciotti F, Caprioli F
    Environmental Protective and Risk Factors in an At-Risk Population of Subsequent Crohn's Disease.
    Gastroenterology. 2023;164:500-501.
    >> Share

    February 2023
  67. DE VOOGD F, D'Haens GR, Gecse KB
    Response to Letters to the Editor regarding: "Intestinal Ultrasound Is Accurate to Determine Endoscopic Response and Remission in Patients With Moderate to Severe Ulcerative Colitis: A Longitudinal Prospective Cohort Study, De Voogd et al.".
    Gastroenterology. 2023 Feb 16:S0016-5085(23)00142.
    >> Share

  68. SHIN A, Kashyap PC
    Promote or Prevent? Gut Microbial Function and Immune Status May Determine the Effect of Fiber in Inflammatory Bowel Disease.
    Gastroenterology. 2023;164:182-184.
    >> Share

  69. RATH T, Atreya R, Bodenschatz J, Uter W, et al
    Intestinal Barrier Healing Is Superior to Endoscopic and Histologic Remission for Predicting Major Adverse Outcomes in Inflammatory Bowel Disease: The Prospective ERIca Trial.
    Gastroenterology. 2023;164:241-255.
    >> Share

  70. LIU Z, Alexander JL, Lin KW, Ahmad T, et al
    Infliximab and Tofacitinib Attenuate Neutralizing Antibody Responses Against SARS-CoV-2 Ancestral and Omicron Variants in Inflammatory Bowel Disease Patients After 3 Doses of COVID-19 Vaccine.
    Gastroenterology. 2023;164:300-303.
    >> Share

  71. WINE E
    Eliminating Pathobionts With Bacteriophages: A Novel Approach to Reduce Gut Inflammation in Inflammatory Bowel Diseases?
    Gastroenterology. 2023;164:304.
    >> Share

  72. RESEGOTTI A, Ribaldone DG
    Is a Protective Stoma Mandatory in Anti-Tumor Necrosis Factor-Treated Crohn's Disease Patients Undergoing Surgery?
    Gastroenterology. 2023;164:307.
    >> Share

    January 2023
  73. ALLOCCA M, Kucharzik T, Rubin DT
    Intestinal Ultrasound in the Assessment and Management of Inflammatory Bowel Disease: Is it Ready for Standard Practice?
    Gastroenterology. 2023 Jan 25:S0016-5085(23)00054.
    >> Share

  74. KOTLARZ D
    Identification of the gammadelta IEL-secreted Paneth cell protective factor API5 as a promising therapeutic target for ATG16L1-associated Crohn's disease.
    Gastroenterology. 2023 Jan 18:S0016-5085(23)00046.
    >> Share

  75. NGUYEN V, Cominelli F, Chak A
    Bowel Wall Layer Thickness in Ulcerative Colitis on Endoscopic Ultrasound.
    Gastroenterology. 2023 Jan 16:S0016-5085(23)00041.
    >> Share

  76. LIVANOS AE, Dunn A, Fischer J, Ungaro RC, et al
    Anti-integrin alphavbeta6 autoantibodies are a novel biomarker that antedate ulcerative colitis.
    Gastroenterology. 2023 Jan 9:S0016-5085(23)00010.
    >> Share

  77. ZHAO X, Yang W, Yu T, Yu Y, et al
    Th17 Cell-Derived Amphiregulin Promotes Colitis-Associated Intestinal Fibrosis Through Activation of mTOR and MEK in Intestinal Myofibroblasts.
    Gastroenterology. 2023;164:89-102.
    >> Share

  78. PAPAMICHAEL K, Dubinsky MC, Cheifetz AS
    Proactive Therapeutic Drug Monitoring of Adalimumab in Patients With Crohn's Disease.
    Gastroenterology. 2023;164:164-165.
    >> Share

    December 2022
  79. TANG J, Li Q, Chao K
    A rare cause of rapid death in patients with Crohn's disease.
    Gastroenterology. 2022 Dec 30:S0016-5085(22)01457.
    >> Share

  80. VERBURGT CM, Boneh RS, Dunn K
    Reply to Altered Gut Microbiome Composition and Function Are Associated With Gut Barrier Dysfunction in Healthy Relatives of Patients With Crohn's Disease.
    Gastroenterology. 2022 Dec 20:S0016-5085(22)01394.
    >> Share

  81. MARCOVITCH L, Focht G, Carmon N, Tersigni C, et al
    Development and validation of the TUMMY-UC, a Patient Reported Outcome for Pediatric Ulcerative Colitis.
    Gastroenterology. 2022 Dec 17:S0016-5085(22)01390.
    >> Share

    November 2022
  82. LI Y, Pengbo S, Feng Y
    A new evaluation method for remission of ulcerative colitis.
    Gastroenterology. 2022 Nov 22:S0016-5085(22)01345.
    >> Share

  83. KUFTINEC GN, Lim JE, Yarur AJ
    A Rare but Devastating Dermatologic Manifestation of Ulcerative Colitis.
    Gastroenterology. 2022 Nov 3. pii: S0016-5085(22)01253.
    >> Share

  84. BALASUBRAMANIAM M, Nandi N, Aswani-Omprakash T, Sebastian S, et al
    Identifying Care Challenges as Opportunities for Research and Education in Inflammatory Bowel Disease in South Asia.
    Gastroenterology. 2022;163:1145-1150.
    >> Share

  85. GREEN PHR, Paski S, Ko CW, Rubio-Tapia A, et al
    AGA Clinical Practice Update on Management of Refractory Celiac Disease: Expert Review.
    Gastroenterology. 2022;163:1461-1469.
    >> Share

  86. DOLINGER MT, Dubinsky MC
    The Pediatric Inflammatory Crohn's Magnetic Resonance Enterography Index: A Step Forward for Transmural Pediatric Crohn's Disease Monitoring and Healing.
    Gastroenterology. 2022;163:1166-1167.
    >> Share

  87. KHANNA R
    Risankizumab for Induction and Maintenance of Remission in Crohn's Disease.
    Gastroenterology. 2022;163:1470-1471.
    >> Share

  88. FOCHT G, Cytter-Kuint R, Greer MC, Pratt LT, et al
    Development, Validation, and Evaluation of the Pediatric Inflammatory Crohn's Magnetic Resonance Enterography Index From the ImageKids Study.
    Gastroenterology. 2022;163:1306-1320.
    >> Share

  89. LEIBOVITZH H, Lee SH, Xue M, Raygoza Garay JA, et al
    Altered Gut Microbiome Composition and Function Are Associated With Gut Barrier Dysfunction in Healthy Relatives of Patients With Crohn's Disease.
    Gastroenterology. 2022;163:1364-1376.
    >> Share

  90. WU N, Hong SK, Huang WF
    Multiple Strictures of Small Intestine: Is It Crohn's Disease?
    Gastroenterology. 2022;163:e1-e2.
    >> Share

    October 2022
  91. WELZ L, Aden K
    Fibrosis and Inflammation in Inflammatory Bowel Disease-More Than 2 Sides of the Same Coin?
    Gastroenterology. 2022 Oct 29. pii: S0016-5085(22)01246.
    >> Share

  92. FORSS A, Ludvigsson JF, Olen O
    Letter to the Editor regarding "The Rising Burden of Inflammatory Bowel Disease in Denmark over Two Decades: A Nationwide Cohort Study" by Agrawal et al.
    Gastroenterology. 2022 Oct 21. pii: S0016-5085(22)01193.
    >> Share

  93. BOURGONJE AR
    Microbial Riboflavin Biosynthesis Associates with Response to Dietary Fiber Consumption: Time to Personalize Adjunct Therapy in Patients with Inflammatory Bowel Disease?
    Gastroenterology. 2022 Oct 21. pii: S0016-5085(22)01194.
    >> Share

  94. PALMELA C, Maaser C
    The use of intestinal ultrasound in ulcerative colitis - more than a mucosal disease?
    Gastroenterology. 2022 Oct 9. pii: S0016-5085(22)01161.
    >> Share

  95. ALLEZ M
    A CEACAM5-derived Peptide Activating CD8(+) Regulatory T Cells: A Future Option for Restoring Mucosal Homeostasis in Crohn's Disease?
    Gastroenterology. 2022;163:822-824.
    >> Share

  96. SEGAL JP
    Ustekinumab Versus Adalimumab in Patients With Crohn's Disease.
    Gastroenterology. 2022;163:1115-1116.
    >> Share

  97. BRENNER TA, Steinway S
    Penile Necrosis in a Patient With Untreated Crohn's Disease.
    Gastroenterology. 2022;163:832-834.
    >> Share

  98. NGUYEN NH, Solitano V, Vuyyuru SK, MacDonald JK, et al
    Proactive Therapeutic Drug Monitoring Versus Conventional Management for Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis.
    Gastroenterology. 2022;163:937-949.
    >> Share

  99. GLOBIG AM, Mayer LS, Heeg M, Andrieux G, et al
    Exhaustion of CD39-Expressing CD8(+) T Cells in Crohn's Disease Is Linked to Clinical Outcome.
    Gastroenterology. 2022;163:965-981.
    >> Share

  100. DUNKIN D, Merlino F, Correale C, Yeretssian G, et al
    A Small CEACAM5 Peptide Restores the Protective Function of CD8(+) Regulatory T Cells in Crohn's Disease.
    Gastroenterology. 2022;163:1090-1093.
    >> Share

  101. GHIBOUB M, Penny S, Verburgt CM, Boneh RS, et al
    Metabolome Changes With Diet-Induced Remission in Pediatric Crohn's Disease.
    Gastroenterology. 2022;163:922-936.
    >> Share

    September 2022
  102. ARMSTRONG HK, Bording-Jorgensen M, Santer DM, Zhang Z, et al
    Unfermented beta-fructan fibers fuel inflammation in select inflammatory bowel disease patients.
    Gastroenterology. 2022 Sep 29. pii: S0016-5085(22)01150.
    >> Share

  103. UNGARO RC, Kappelman MD
    Reappraisal of COVID-19 Risk for Patients with Inflammatory Bowel Disease (IBD): Withdrawal of the British Society of Gastroenterology IBD Risk Grid.
    Gastroenterology. 2022 Sep 23. pii: S0016-5085(22)01069.
    >> Share

  104. D'AMICO F, Peyrin-Biroulet L, Danese S
    Is Selectivity the JAKpot Winner for Inflammatory Bowel Disease Treatment?
    Gastroenterology. 2022 Sep 22. pii: S0016-5085(22)01065.
    >> Share

  105. HUA X, Ungaro RC, Petrick LM, Chan AT, et al
    Inflammatory Bowel Disease is Associated with Prediagnostic Perturbances in Metabolic Pathways.
    Gastroenterology. 2022 Sep 16. pii: S0016-5085(22)01061.
    >> Share

  106. PEKOW J
    Fatigue in Inflammatory Bowel Disease: A Common Complaint With Few Answers.
    Gastroenterology. 2022 Sep 5. pii: S0016-5085(22)01032.
    >> Share

  107. TURPIN W, Dong M, Sasson G, Raygoza Garay JA, et al
    Mediterranean-Like Dietary Pattern Associations With Gut Microbiome Composition and Subclinical Gastrointestinal Inflammation.
    Gastroenterology. 2022;163:685-698.
    >> Share

  108. PIOVANI D, Hassan C, Repici A, Rimassa L, et al
    Risk of Cancer in Inflammatory Bowel Diseases: Umbrella Review and Reanalysis of Meta-analyses.
    Gastroenterology. 2022;163:671-684.
    >> Share

  109. MORTHA A, Remark R, Del Valle DM, Chuang LS, et al
    Neutralizing Anti-Granulocyte Macrophage-Colony Stimulating Factor Autoantibodies Recognize Post-Translational Glycosylations on Granulocyte Macrophage-Colony Stimulating Factor Years Before Diagnosis and Predict Complicated Crohn's Disease.
    Gastroenterology. 2022;163:659-670.
    >> Share

  110. LE COSQUER G, Zadro C, Gilletta C
    A Rare Pregnancy-related Complication of Crohn's Disease: Diagnosis and Treatment.
    Gastroenterology. 2022;163:586-587.
    >> Share

    August 2022
  111. DE VOOGD F, van Wassenaer EA, Mookhoek A, Bots S, et al
    Intestinal ultrasound is accurate to determine endoscopic response and remission in patients with moderate to severe ulcerative colitis: a longitudinal prospective cohort study.
    Gastroenterology. 2022 Aug 24. pii: S0016-5085(22)00966.
    >> Share

  112. CLEVELAND NK, Bressler B, Siegel CA
    A Summary of the BRIDGe Summit on Damage-Related Progression of Ulcerative Colitis: Establishing Research Priorities.
    Gastroenterology. 2022 Aug 11. pii: S0016-5085(22)00925.
    >> Share

  113. CHEN B, Zhong J, Li X, Pan F, et al
    Efficacy and Safety of Ivarmacitinib in Patients with Moderate-to-Severe, Active, Ulcerative Colitis: A Phase II Study.
    Gastroenterology. 2022 Aug 10. pii: S0016-5085(22)00918.
    >> Share

  114. BELLUSCI L, Zahra FT, Hopkins DE, Salazar JC, et al
    Durability of Immunity is low against SARS-CoV-2 Omicron BA.1, BA.2 and BA.3 variants following second and third vaccination in children and young adults with Inflammatory Bowel Disease receiving biologics.
    Gastroenterology. 2022 Aug 10. pii: S0016-5085(22)00920.
    >> Share

  115. AGRAWAL M, Christensen HS, Bogsted M, Colombel JF, et al
    The rising burden of inflammatory bowel disease in Denmark over two decades: a nationwide cohort study.
    Gastroenterology. 2022 Aug 8. pii: S0016-5085(22)00881.
    >> Share

  116. TRUYENS M, Lobaton T, Ferrante M, Bossuyt P, et al
    Effect of 5-hydroxytryptophan on fatigue in quiescent inflammatory bowel disease: a randomized controlled trial.
    Gastroenterology. 2022 Aug 5. pii: S0016-5085(22)00828.
    >> Share

  117. ZOLLNER A, Koch R, Jukic A, Pfister A, et al
    Postacute COVID-19 is Characterized by Gut Viral Antigen Persistence in Inflammatory Bowel Diseases.
    Gastroenterology. 2022;163:495-506.
    >> Share

    July 2022
  118. CROWLEY E, Griffiths AM, Jairath V
    Heterogeneity in Efficacy and Safety Endpoints for Pediatric Clinical Trials in Inflammatory Bowel Disease: A Need for Harmonization.
    Gastroenterology. 2022 Jul 15. pii: S0016-5085(22)00778.
    >> Share

  119. SPENCER EA, Dubinsky MC
    Failure to Achieve Target Drug Concentrations During Induction and Not HLA-DQA1*05 Carriage is Associated with Anti-Drug Antibody Formation in Patients with Inflammatory Bowel Disease: HLA-DQA1*05 Testing for Immunogenicity to anti-TNF Remains Relevan
    Gastroenterology. 2022 Jul 6. pii: S0016-5085(22)00748.
    >> Share

  120. WINE E
    Expanding Links Between Gut Microbiota and Bowel Inflammation.
    Gastroenterology. 2022;163:333-334.
    >> Share

  121. KUANG AG, Bahdi F, Shukla R
    Unusual Skin Ulcerations in a Patient With Hematochezia.
    Gastroenterology. 2022;163:e7-e9.
    >> Share

  122. MA C, Hanzel J, Panaccione R, Sandborn WJ, et al
    CORE-IBD: A Multidisciplinary International Consensus Initiative to Develop a Core Outcome Set for Randomized Controlled Trials in Inflammatory Bowel Disease.
    Gastroenterology. 2022 Jul 1. pii: S0016-5085(22)00730.
    >> Share

    June 2022
  123. HOUNTONDJI L, Rudler F, Blanc P
    An atypical cause of musculoskeletal pain in a patient with chronic inflammatory bowel disease.
    Gastroenterology. 2022 Jun 28. pii: S0016-5085(22)00727.
    >> Share

  124. MURAMOTO Y, Nihira H, Shiokawa M, Izawa K, et al
    Anti-integrin alphavbeta6 antibody as a diagnostic marker for pediatric patients with ulcerative colitis.
    Gastroenterology. 2022 Jun 13. pii: S0016-5085(22)00631.
    >> Share

  125. RICCIUTO A, Rauter I, McGovern DPB, Mader RM, et al
    Precision Medicine in Inflammatory Bowel Diseases: Challenges and Considerations for the Path Forward.
    Gastroenterology. 2022;162:1815-1821.
    >> Share

  126. DELSUPEHE AM, Bourgain C, Bossuyt P
    Subtle Trap for the Inflammatory Bowel Disease Endoscopy Central Reader.
    Gastroenterology. 2022;162:1849-1851.
    >> Share

  127. HANZEL J, Ma C, Jairath V
    Design of Clinical Trials for Mild to Moderate Crohn's Disease.
    Gastroenterology. 2022;162:1800-1814.
    >> Share

  128. LIU CY, Girish N, Gomez ML, Dube PE, et al
    Transitional Anal Cells Mediate Colonic Re-epithelialization in Colitis.
    Gastroenterology. 2022;162:1975-1989.
    >> Share

  129. D'HAENS GR, Sandborn WJ, Loftus EV Jr, Hanauer SB, et al
    Higher vs Standard Adalimumab Induction Dosing Regimens and Two Maintenance Strategies: Randomized SERENE CD Trial Results.
    Gastroenterology. 2022;162:1876-1890.
    >> Share

  130. ZHU Z, Gao Z, Li K
    Controversy of Preoperative Exposure to Tumor Necrosis Factor Inhibitors in Surgical and Infectious Complications of Inflammatory Bowel Disease.
    Gastroenterology. 2022 Jun 1. pii: S0016-5085(22)00588.
    >> Share

    May 2022
  131. TANG J, Wang JP, Chao K
    An Unusual Cause of Chronic Pancreatitis in a Patient with Crohn's Disease.
    Gastroenterology. 2022 May 18. pii: S0016-5085(22)00521.
    >> Share

  132. SABINO J
    Understanding the Role of PUFAs in Crohn's Disease.
    Gastroenterology. 2022;162:1590-1591.
    >> Share

  133. SANDBORN WJ, D'Haens GR, Reinisch W, Panes J, et al
    Guselkumab for the Treatment of Crohn's Disease: Induction Results From the Phase 2 GALAXI-1 Study.
    Gastroenterology. 2022;162:1650-1664.
    >> Share

  134. SHODA T, Collins MH, Rochman M, Wen T, et al
    Evaluating Eosinophilic Colitis as a Unique Disease Using Colonic Molecular Profiles: A Multi-Site Study.
    Gastroenterology. 2022;162:1635-1649.
    >> Share

  135. SCHWARZLER J, Mayr L, Vich Vila A, Grabherr F, et al
    PUFA-Induced Metabolic Enteritis as a Fuel for Crohn's Disease.
    Gastroenterology. 2022;162:1690-1704.
    >> Share

    April 2022
  136. CROSS RK, Keefer L
    Chicken or Egg, Mental Health Disorders in Inflammatory Bowel Disease: Does It Matter?
    Gastroenterology. 2022 Apr 29. pii: S0016-5085(22)00454.
    >> Share

  137. MA J, Wang Y, Cao H
    When neurology meets gastroenterology: an unusual case of ulcerative colitis.
    Gastroenterology. 2022 Apr 27. pii: S0016-5085(22)00447.
    >> Share

  138. WILSON A, Kim RB
    Correspondence: Failure to Achieve Target Drug Concentrations During Induction and Not HLA- DQA1*05 Carriage is Associated with Anti-Drug Antibody Formation in Patients with Inflammatory Bowel Disease - Is HLADQA1*05 gone before it's here?
    Gastroenterology. 2022 Apr 12. pii: S0016-5085(22)00367.
    >> Share

  139. COHEN BL, Fleshner P, Kane SV, Herfarth HH, et al
    Prospective Cohort Study to Investigate the Safety of Preoperative Tumor Necrosis Factor Inhibitor Exposure in Patients with Inflammatory Bowel Disease Undergoing Intra-abdominal Surgery.
    Gastroenterology. 2022 Apr 9. pii: S0016-5085(22)00359.
    >> Share

  140. IRVING PM, Gecse KB
    Optimizing Therapies Using Therapeutic Drug Monitoring: Current Strategies and Future Perspectives.
    Gastroenterology. 2022;162:1512-1524.
    >> Share

  141. PLEVRIS N, Lees CW
    Disease Monitoring in Inflammatory Bowel Disease: Evolving Principles and Possibilities.
    Gastroenterology. 2022;162:1456-1475.
    >> Share

  142. STIDHAM RW, Takenaka K
    Artificial Intelligence for Disease Assessment in Inflammatory Bowel Disease: How Will it Change Our Practice?
    Gastroenterology. 2022;162:1493-1506.
    >> Share

  143. VERSTOCKT B, Parkes M, Lee JC
    How Do We Predict a Patient's Disease Course and Whether They Will Respond to Specific Treatments?
    Gastroenterology. 2022;162:1383-1395.
    >> Share

  144. VERSTOCKT B, Bressler B, Martinez-Lozano H, McGovern D, et al
    Time to Revisit Disease Classification in Inflammatory Bowel Disease: Is the Current Classification of Inflammatory Bowel Disease Good Enough for Optimal Clinical Management?
    Gastroenterology. 2022;162:1370-1382.
    >> Share

  145. WILKENS R, Dolinger M, Burisch J, Maaser C, et al
    Point-of-Care Testing and Home Testing: Pragmatic Considerations for Widespread Incorporation of Stool Tests, Serum Tests, and Intestinal Ultrasound.
    Gastroenterology. 2022;162:1476-1492.
    >> Share

  146. LE BERRE C, Ricciuto A, Peyrin-Biroulet L, Turner D, et al
    Evolving Short- and Long-Term Goals of Management of Inflammatory Bowel Diseases: Getting It Right, Making It Last.
    Gastroenterology. 2022;162:1424-1438.
    >> Share

  147. KEEFER L, Bedell A, Norton C, Hart AL, et al
    How Should Pain, Fatigue, and Emotional Wellness Be Incorporated Into Treatment Goals for Optimal Management of Inflammatory Bowel Disease?
    Gastroenterology. 2022;162:1439-1451.
    >> Share

    March 2022
  148. VERSTOCKT S, Torres J, Verstockt B
    THE ROAD TO PROGNOSTICATION? A FIVE-PROTEIN PANEL PREDICTING DISEASE COURSE IN INFLAMMATORY BOWEL DISEASE.
    Gastroenterology. 2022 Mar 23. pii: S0016-5085(22)00289.
    >> Share

  149. FAIRBRASS KM, Gracie DJ, Ford AC
    Relative Contribution of Disease Activity and Psychological Health to Prognosis of Inflammatory Bowel Disease During 6.5 years of Longitudinal Follow-up.
    Gastroenterology. 2022 Mar 23. pii: S0016-5085(22)00265.
    >> Share

  150. REVES J, Chapman TP, Satsangi J, Torres J, et al
    Probing the Microbiome to Predict Response to Biologic Therapy in Inflammatory Bowel Disease-One Step Closer to Precision Medicine?
    Gastroenterology. 2022 Mar 23. pii: S0016-5085(22)00290.
    >> Share

  151. RABINOWITZ LG, Rabinowitz DG, Silver EM, Oxentenko AS, et al
    Disparities persist in inclusion of female, pregnant, lactating, and older individuals in inflammatory bowel disease clinical trials.
    Gastroenterology. 2022 Mar 11. pii: S0016-5085(22)00267.
    >> Share

  152. HAYASHI Y, Nakase H, Hisamatsu T
    Should we continue or discontinue inflammatory bowel disease medication in patients with COVID-19?
    Gastroenterology. 2022 Mar 11. pii: S0016-5085(22)00239.
    >> Share

  153. HU MD, Golovchenko NB, Burns GL, Nair PM, et al
    gammadelta Intraepithelial Lymphocytes Facilitate Pathological Epithelial Cell Shedding Via CD103-Mediated Granzyme Release.
    Gastroenterology. 2022;162:877-889.
    >> Share

  154. GOBERT AP, Latour YL, Asim M, Barry DP, et al
    Protective Role of Spermidine in Colitis and Colon Carcinogenesis.
    Gastroenterology. 2022;162:813-827.
    >> Share

    February 2022
  155. PANES J, Colombel JF, D'Haens GR, Schreiber S, et al
    Higher vs Standard Adalimumab Induction and Maintenance Dosing Regimens for Treatment of Ulcerative Colitis: SERENE UC Trial Results.
    Gastroenterology. 2022 Feb 25. pii: S0016-5085(22)00199.
    >> Share

  156. HART A, Rubin DT
    Entering the Era of Disease Modification in Inflammatory Bowel Disease.
    Gastroenterology. 2022 Feb 11. pii: S0016-5085(22)00141.
    >> Share

  157. ABRAHAM C, Abreu MT, Turner JR
    Pattern Recognition Receptor Signaling and Cytokine Networks in Microbial Defenses and Regulation of Intestinal Barriers: Implications for Inflammatory Bowel Disease.
    Gastroenterology. 2022 Feb 8. pii: S0016-5085(22)00125.
    >> Share

  158. KHANNA R, Chande N, Marshall JK
    Ozanimod for the Treatment of Ulcerative Colitis.
    Gastroenterology. 2022 Feb 2. pii: S0016-5085(22)00088.
    >> Share

  159. EDELMAN-KLAPPER H, Zittan E, Bar-Gil Shitrit A, Rabinowitz KM, et al
    Lower Serologic Response to COVID-19 mRNA Vaccine in Patients With Inflammatory Bowel Diseases Treated With Anti-TNFalpha.
    Gastroenterology. 2022;162:454-467.
    >> Share

  160. SANDS BE, Peyrin-Biroulet L, Kierkus J, Higgins PDR, et al
    Efficacy and Safety of Mirikizumab in a Randomized Phase 2 Study of Patients With Crohn's Disease.
    Gastroenterology. 2022;162:495-508.
    >> Share

  161. STADNIK A, Wojcicki M, Milkiewicz P
    Splenic Tumor in a Patient After Liver Transplantation.
    Gastroenterology. 2022;162:e14-e15.
    >> Share

    January 2022
  162. CLEVELAND NK, Torres J, Rubin DT
    WHAT DOES DISEASE PROGRESSION LOOK LIKE IN ULCERATIVE COLITIS AND HOW MIGHT IT BE PREVENTED?
    Gastroenterology. 2022 Jan 28. pii: S0016-5085(22)00077.
    >> Share

  163. SPENCER EA, Stachelski J, Dervieux T, Dubinsky MC, et al
    Failure to Achieve Target Drug Concentrations During Induction and Not HLA-DQA1*05 Carriage is Associated with Anti-Drug Antibody Formation in Patients with Inflammatory Bowel Disease.
    Gastroenterology. 2022 Jan 10. pii: S0016-5085(22)00017.
    >> Share

  164. SEDANO R, Jairath V, Ma C, Sedano R, et al
    Design of clinical trials for mild-to-moderate ulcerative colitis.
    Gastroenterology. 2022 Jan 5. pii: S0016-5085(22)00004.
    >> Share

  165. PRATT M, Forbes JD, Knox NC, Van Domselaar G, et al
    Colorectal cancer screening in IBD - can characterization of GI microbiome signatures enhance neoplasia detection?
    Gastroenterology. 2022 Jan 5. pii: S0016-5085(22)00007.
    >> Share

  166. KUENZIG ME, Fung SG, Marderfeld L, Mak JW, et al
    Twenty-first century trends in the global epidemiology of pediatric-onset inflammatory bowel disease: systematic review.
    Gastroenterology. 2022 Jan 4. pii: S0016-5085(22)00002.
    >> Share

  167. LEVINE I, Swaminath A, Roitman I, Sultan K, et al
    COVID-19 Vaccination and Inflammatory Bowel Disease: Desired Antibody Responses, Future Directions, and a Note of Caution.
    Gastroenterology. 2022;162:349-350.
    >> Share

  168. SAKURABA A, Luna A, Micic D
    Serologic Response to Coronavirus Disease 2019 (COVID-19) Vaccination in Patients With Immune-Mediated Inflammatory Diseases: A Systematic Review and Meta-analysis.
    Gastroenterology. 2022;162:88-108.
    >> Share

  169. SEDANO R, Hogan M, Mcdonald C, Aswani-Omprakash T, et al
    Underrepresentation of Minorities and Underreporting of Race and Ethnicity in Crohn's Disease Clinical Trials.
    Gastroenterology. 2022;162:338-340.
    >> Share

  170. YANG W, Liu H, Xu L, Yu T, et al
    GPR120 Inhibits Colitis Through Regulation of CD4(+) T Cell Interleukin 10 Production.
    Gastroenterology. 2022;162:150-165.
    >> Share

  171. BECKER HEF, Penders J, Jonkers DMAE
    Microbial Metabolism of Inflammatory Bowel Disease Drugs: Current Evidence and Clinical Implementations.
    Gastroenterology. 2022;162:4-8.
    >> Share

  172. D'HAENS G, Rieder F, Feagan BG, Higgins PDR, et al
    Challenges in the Pathophysiology, Diagnosis, and Management of Intestinal Fibrosis in Inflammatory Bowel Disease.
    Gastroenterology. 2022;162:26-31.
    >> Share

  173. ALTEPETER T, Wertheimer E, Lee JJ
    Expediting Drug Development for Pediatric Inflammatory Bowel Disease: A Workshop to Identify Barriers and Move Forward.
    Gastroenterology. 2022;162:22-25.
    >> Share

    December 2021
  174. LAMB CA, Saifuddin A, Powell N, Rieder F, et al
    The future of precision medicine to predict outcomes and control tissue remodeling in inflammatory bowel disease.
    Gastroenterology. 2021 Dec 14. pii: S0016-5085(21)04069.
    >> Share

  175. TORRES J, Ungaro RC, Colombel JF
    Is prevention the best way to modify inflammatory bowel disease? How close are we?
    Gastroenterology. 2021 Dec 11. pii: S0016-5085(21)04071.
    >> Share

  176. D'AMICO F, Allocca M, Fiorino G
    Positioning ozanimod in ulcerative colitis: restoring leukocyte traffic under control.
    Gastroenterology. 2021 Dec 8. pii: S0016-5085(21)04063.
    >> Share

  177. DARGENIO VN, Cristofori F, Francavilla R
    An unexpected guest in a patient with ulcerative colitis.
    Gastroenterology. 2021 Dec 2. pii: S0016-5085(21)04041.
    >> Share

  178. FAYE AS, Dodson JA, Shaukat A
    Safety and Efficacy of Anti-TNF Therapy in Older Adults with Ulcerative Colitis: A New Path Forward.
    Gastroenterology. 2021 Dec 2. pii: S0016-5085(21)03816.
    >> Share

  179. SHEEHAN JL, Cohen-Mekelburg S
    Positioning infliximab and vedolizumab in the treatment of moderate-to-severe ulcerative colitis.
    Gastroenterology. 2021 Dec 2. pii: S0016-5085(21)03815.
    >> Share

  180. CHAPMAN TP, Reves J, Torres J, Satsangi J, et al
    Anti-SARS-CoV-2 Antibody Responses in Patients With IBD Treated With Biologics: Are We Finding CLARITY?
    Gastroenterology. 2021;161:2057-2059.
    >> Share

  181. GOLD SL, Cohen-Mekelburg S
    An Apple a Day Keeps the Doctor Away: The Effect of a Low-Fat, High-Fiber Diet on Quality of Life, Inflammation, and Dysbiosis in Patients with Ulcerative Colitis.
    Gastroenterology. 2021 Dec 1. pii: S0016-5085(21)03810.
    >> Share

  182. LI X, Liang D, Huang B
    Reply.
    Gastroenterology. 2021;161:2066-2067.
    >> Share

  183. ZHANG B, Zhang S
    The Potential of Radiomics in the Assessment of Intestinal Fibrosis in Crohn's Disease.
    Gastroenterology. 2021;161:2065-2066.
    >> Share

  184. KUO WT, Zuo L, Odenwald MA, Madha S, et al
    The Tight Junction Protein ZO-1 Is Dispensable for Barrier Function but Critical for Effective Mucosal Repair.
    Gastroenterology. 2021;161:1924-1939.
    >> Share

    November 2021
  185. DI NARZO AF, Houten SM, Kosoy R, Huang R, et al
    Integrative analysis of the Inflammatory Bowel Disease serum metabolome improves our understanding of genetic etiology and points to novel putative therapeutic targets.
    Gastroenterology. 2021 Nov 12. pii: S0016-5085(21)03738.
    >> Share

  186. BOLTON C, Smillie CS, Pandey S, Elmentaite R, et al
    An integrated taxonomy for monogenic inflammatory bowel disease.
    Gastroenterology. 2021 Nov 12. pii: S0016-5085(21)03737.
    >> Share

  187. CAO Y, Wang Z, Yan Y, Ji L, et al
    Enterotoxigenic Bacteroidesfragilis Promotes Intestinal Inflammation and Malignancy by Inhibiting Exosome-Packaged miR-149-3p.
    Gastroenterology. 2021;161:1552-1566.
    >> Share

  188. LEE SH, Turpin W, Espin-Garcia O, Raygoza Garay JA, et al
    Anti-Microbial Antibody Response is Associated With Future Onset of Crohn's Disease Independent of Biomarkers of Altered Gut Barrier Function, Subclinical Inflammation, and Genetic Risk.
    Gastroenterology. 2021;161:1540-1551.
    >> Share

    October 2021
  189. SHAH SC, Itzkowitz SH
    Colorectal Cancer in Inflammatory Bowel Disease: Mechanisms and Management.
    Gastroenterology. 2021 Oct 29. pii: S0016-5085(21)03707.
    >> Share

  190. BEN-HORIN S, Novack L, Mao R, Guo J, et al
    Efficacy of biologic drugs in short-duration versus long-duration inflammatory bowel disease: A systematic review and an individual-patient data meta-analysis of randomized controlled trials.
    Gastroenterology. 2021 Oct 29. pii: S0016-5085(21)03709.
    >> Share

  191. SPIERA E, Agrawal M, Ungaro R
    COVID-19 mRNA Vaccine Short-Term Safety in Patients with Inflammatory Bowel Disease.
    Gastroenterology. 2021 Oct 6. pii: S0016-5085(21)03619.
    >> Share

  192. KAPPELMAN MD, Weaver KN, Boccieri M, Firestine A, et al
    Humoral Immune Response to Messenger RNA COVID-19 Vaccines Among Patients With Inflammatory Bowel Disease.
    Gastroenterology. 2021;161:1340-1343.
    >> Share

  193. LIMA S, Gogokhia L, Viladomiu M, Chou L, et al
    Transferable IgA-coated Odoribacter splanchnicus in Responders to Fecal Microbiota Transplantation for Ulcerative Colitis Limits Colonic Inflammation.
    Gastroenterology. 2021 Oct 1. pii: S0016-5085(21)03610.
    >> Share

  194. SASSON SC, Slevin SM, Cheung VTF, Nassiri I, et al
    Interferon-Gamma-Producing CD8(+) Tissue Resident Memory T Cells Are a Targetable Hallmark of Immune Checkpoint Inhibitor-Colitis.
    Gastroenterology. 2021;161:1229-1244.
    >> Share

  195. XIAO L, Ma XX, Luo J, Chung HK, et al
    Circular RNA CircHIPK3 Promotes Homeostasis of the Intestinal Epithelium by Reducing MicroRNA 29b Function.
    Gastroenterology. 2021;161:1303-1317.
    >> Share

    September 2021
  196. CLEVELAND NK, Rai V, El Jurdi K, Rao SS, et al
    ULCERATIVE COLITIS PATIENTS HAVE REDUCED RECTAL COMPLIANCE COMPARED WITH NON-IBD CONTROLS.
    Gastroenterology. 2021 Sep 28. pii: S0016-5085(21)03564.
    >> Share

  197. SUGIMOTO S, Iwao Y, Shimoda M, Takabayashi K, et al
    Epithelium Replacement Contributes to Field Expansion of Squamous Epithelium and Ulcerative Colitis-Associated Neoplasia.
    Gastroenterology. 2021 Sep 28. pii: S0016-5085(21)03563.
    >> Share

  198. COHEN NA, Silfen A, Rubin DT
    Inclusion of Under-Represented Racial and Ethnic Minorities in Randomized Clinical Trials for Inflammatory Bowel Disease.
    Gastroenterology. 2021 Sep 22. pii: S0016-5085(21)03535.
    >> Share

  199. KHANNA R, Wilson AS, Gregor JC, Prowse KL, et al
    Clinical Guidelines for the Management of Inflammatory Bowel Disease.
    Gastroenterology. 2021 Sep 14. pii: S0016-5085(21)03521.
    >> Share

  200. PANES J
    Integrin inhibitors in inflammatory bowel disease: from therapeutic antibodies to small molecule drugs.
    Gastroenterology. 2021 Sep 13. pii: S0016-5085(21)03495.
    >> Share

  201. KONDO A, Ma S, Lee MYY, Ortiz V, et al
    Highly multiplexed image analysis of intestinal tissue sections in patients with inflammatory bowel disease.
    Gastroenterology. 2021 Sep 13. pii: S0016-5085(21)03480.
    >> Share

  202. UNGARO RC, Brenner EJ, Agrawal M, Zhang X, et al
    Impact of Medications on COVID-19 Outcomes in Inflammatory Bowel Disease: Analysis of Over 6,000 Patients from an International Registry.
    Gastroenterology. 2021 Sep 13. pii: S0016-5085(21)03490.
    >> Share

  203. ALLIN KH, Moayyedi P
    Proton pump inhibitor use - a risk factor for inflammatory bowel disease or an innocent bystander?
    Gastroenterology. 2021 Sep 6. pii: S0016-5085(21)03478.
    >> Share

  204. VAN DE GUCHTE M, Mondot S, Dore J
    Dynamic properties of the intestinal ecosystem call for combination therapies, targeting inflammation and microbiota, in ulcerative colitis.
    Gastroenterology. 2021 Sep 6. pii: S0016-5085(21)03482.
    >> Share

  205. ARGMANN C, Tokuyama M, Ungaro RC, Huang R, et al
    Molecular characterization of limited ulcerative colitis reveals novel biology and predictors of disease extension.
    Gastroenterology. 2021 Sep 1. pii: S0016-5085(21)03472.
    >> Share

  206. TURNER D, Hanauer SB
    Which Diet for Crohn's Disease? Food for Thought on the Specific Carbohydrate Diet, Mediterranean Diet, and Beyond.
    Gastroenterology. 2021;161:798-800.
    >> Share

  207. SPARROW MP
    Quantification of Digestive Disease Damage in Crohn's Disease, Are We There Yet With the Lemann Index?
    Gastroenterology. 2021;161:800-802.
    >> Share

  208. PONSIOEN CY, de Jonge WJ
    Feeding the Gut-Liver Axis in PSC: What Makes It Different from IBD?
    Gastroenterology. 2021;161:1070-1071.
    >> Share

  209. SOFFER S, Kopylov U, Klang E
    Artificial Intelligence for the Evaluation of Mucosal Healing in IBD: The Future is Here.
    Gastroenterology. 2021;161:1073-1074.
    >> Share

  210. MURTHY SK, Feuerstein JD, Nguyen GC, Velayos FS, et al
    AGA Clinical Practice Update on Endoscopic Surveillance and Management of Colorectal Dysplasia in Inflammatory Bowel Diseases: Expert Review.
    Gastroenterology. 2021;161:1043-1051.
    >> Share

  211. LEWIS JD, Sandler RS, Brotherton C, Brensinger C, et al
    A Randomized Trial Comparing the Specific Carbohydrate Diet to a Mediterranean Diet in Adults With Crohn's Disease.
    Gastroenterology. 2021;161:837-852.
    >> Share

  212. PARIENTE B, Torres J, Burisch J, Arebi N, et al
    Validation and Update of the Lemann Index to Measure Cumulative Structural Bowel Damage in Crohn's Disease.
    Gastroenterology. 2021;161:853-864.
    >> Share

  213. LE PH, Kuo CJ, Wu RC
    Colonic Bluish-Black Patches in a 57-Year-Old Woman with Crohn's Disease.
    Gastroenterology. 2021;161:e10-e11.
    >> Share

    August 2021
  214. SANDBORN W, Mattheakis LC, Modi NB, Pugatch D, et al
    PTG-100, an Oral alpha4beta7 Antagonist Peptide: Preclinical Development and Phase 1 and 2a Studies in Ulcerative Colitis.
    Gastroenterology. 2021 Aug 30. pii: S0016-5085(21)03463.
    >> Share

  215. BARBERIO B, Massimi D, Cazzagon N, Zingone F, et al
    Prevalence of Primary Sclerosing Cholangitis in Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.
    Gastroenterology. 2021 Aug 20. pii: S0016-5085(21)03412.
    >> Share

  216. POZDNYAKOVA V, Botwin GJ, Sobhani K, Prostko J, et al
    Decreased Antibody Responses to Ad26.COV2.S Relative to SARS-CoV-2 mRNA Vaccines in Patients with Inflammatory Bowel Disease.
    Gastroenterology. 2021 Aug 12. pii: S0016-5085(21)03360.
    >> Share

  217. KUWADA T, Shiokawa M, Seno H
    Two novel autoantibodies in patients with ulcerative colitis.
    Gastroenterology. 2021 Aug 10. pii: S0016-5085(21)03354.
    >> Share

  218. XIA B, Yang M, Nguyen LH, He Q, et al
    Regular use of proton pump inhibitor and the risk of inflammatory bowel disease: pooled analysis of three prospective cohorts.
    Gastroenterology. 2021 Aug 10. pii: S0016-5085(21)03350.
    >> Share

  219. ROGLER G, Singh A, Kavanaugh A, Rubin DT, et al
    Extraintestinal Manifestations of Inflammatory Bowel Disease: Current Concepts, Treatment, and Implications for Disease Management.
    Gastroenterology. 2021 Aug 3. pii: S0016-5085(21)03337.
    >> Share

  220. JONES JL, Tse F, Carroll MW, deBruyn JC, et al
    Canadian Association of Gastroenterology Clinical Practice Guideline for Immunizations in Patients With Inflammatory Bowel Disease (IBD)-Part 2: Inactivated Vaccines.
    Gastroenterology. 2021;161:681-700.
    >> Share

  221. WONG SY, Dixon R, Martinez Pazos V, Gnjatic S, et al
    Serologic Response to Messenger RNA Coronavirus Disease 2019 Vaccines in Inflammatory Bowel Disease Patients Receiving Biologic Therapies.
    Gastroenterology. 2021;161:715-718.
    >> Share

  222. SARTOR RB
    Targeting Adaptive Immune Responses to Human Bacterial Flagellins in Crohn's Disease.
    Gastroenterology. 2021;161:416-418.
    >> Share

  223. DUBINSKY MC, Collins R, Abreu MT
    Challenges and Opportunities in IBD Clinical Trial Design.
    Gastroenterology. 2021;161:400-404.
    >> Share

  224. ALEXANDER KL, Zhao Q, Reif M, Rosenberg AF, et al
    Human Microbiota Flagellins Drive Adaptive Immune Responses in Crohn's Disease.
    Gastroenterology. 2021;161:522-535.
    >> Share

  225. FURFARO F, Solitano V, Danese S
    An Unusual Case of Cardiac Involvement in Crohn's Disease.
    Gastroenterology. 2021;161:431-433.
    >> Share

    July 2021
  226. BERGEMALM D, Andersson E, Hultdin J, Eriksson C, et al
    Systemic inflammation in pre-clinical ulcerative colitis.
    Gastroenterology. 2021 Jul 20. pii: S0016-5085(21)03277.
    >> Share

  227. MEDERACKE I, Wiestler M, Wedemeyer H
    An unusual cause of erythema on both lower legs in a patient with Crohn s disease.
    Gastroenterology. 2021 Jul 16. pii: S0016-5085(21)03249.
    >> Share

  228. LECHNER K, Mott S, Al-Saifi R, Knipfer L, et al
    Targeting of the Tec kinase ITK drives resolution of T cell-mediated colitis and emerges as potential therapeutic option in ulcerative colitis.
    Gastroenterology. 2021 Jul 3. pii: S0016-5085(21)03186.
    >> Share

  229. BEN-TOV A, Banon T, Chodick G, Kariv R, et al
    BNT162b2 mRNA COVID-19 Vaccine Effectiveness in Patients with Inflammatory Bowel Disease: Preliminary Real World Data during Mass Vaccination Campaign.
    Gastroenterology. 2021 Jul 2. pii: S0016-5085(21)03233.
    >> Share

  230. PAPA A, Gasbarrini A, Lopetuso LR
    Winter Is Coming and COVID-19 Vaccine Is Available! The Role of Gastroenterologist in Increasing COVID-19 Vaccine Acceptability Among IBD Patients.
    Gastroenterology. 2021;161:368-369.
    >> Share

  231. RODRIGUEZ-PALACIOS A, Basson AR, Cominelli F
    Artificial Sweeteners and Whole-Food Science: Could Mice Help Clinicians Make Diet Recommendations for IBD Patients?
    Gastroenterology. 2021;161:8-14.
    >> Share

  232. DE A, Chen W, Li H, Wright JR, et al
    Bacterial Swarmers Enriched During Intestinal Stress Ameliorate Damage.
    Gastroenterology. 2021;161:211-224.
    >> Share

    June 2021
  233. TAKADA Y, Ishikawa T, Kawashima H
    An unusual pancreatic mass with ductal disruption: benign or malignant?
    Gastroenterology. 2021 Jun 26. pii: S0016-5085(21)03173.
    >> Share

  234. REINISCH W
    PEG and mucosal biofilms in irritable bowel syndrome and ulcerative colitis.
    Gastroenterology. 2021 Jun 24. pii: S0016-5085(21)03167.
    >> Share

  235. BAUMGARTNER M, Lang M, Holley H, Crepaz D, et al
    Mucosal biofilms are an endoscopic feature of irritable bowel syndrome and ulcerative colitis.
    Gastroenterology. 2021 Jun 16. pii: S0016-5085(21)03138.
    >> Share

  236. PEYRIN-BIROULET L, Loftus EV Jr, Colombel JF, Danese S, et al
    Histologic Outcomes With Vedolizumab Versus Adalimumab in Ulcerative Colitis: Results From VARSITY.
    Gastroenterology. 2021 Jun 15. pii: S0016-5085(21)03126.
    >> Share

  237. HADI YB, Thakkar S, Shah-Khan SM, Hutson W, et al
    COVID-19 vaccination is safe and effective in patients with inflammatory bowel disease: Analysis of a large multi-institutional research network in United States.
    Gastroenterology. 2021 Jun 15. pii: S0016-5085(21)03125.
    >> Share

  238. MAHMUD N, Weiss A, Trivedi C, Yang YX, et al
    Risk of Venous Thromboembolism among Inflammatory Bowel Disease patients who contract SARS-CoV-2.
    Gastroenterology. 2021 Jun 14. pii: S0016-5085(21)03123.
    >> Share

  239. NARULA N, Wong ECL, Dehghan M, Marshall JK, et al
    BRIEF COMMUNICATION: Does High Inflammatory Diet Increase Risk of Inflammatory Bowel Disease? Results from the Prospective Urban Rural Epidemiology (PURE) study: A Prospective Cohort Study.
    Gastroenterology. 2021 Jun 9. pii: S0016-5085(21)03096.
    >> Share

  240. BARBERIO B, Buda A, Savarino EV
    Should Patients With Inflammatory Bowel Disease Be Tested for Active COVID-19 Before Starting a Biological Treatment?
    Gastroenterology. 2021;160:2626-2627.
    >> Share

  241. BEZZIO C, Saibeni S
    Severe Inflammatory Bowel Disease Flares and COVID-19: Expand the Gastroenterology-Surgery Team to Include an Infectious Disease Specialist.
    Gastroenterology. 2021;160:2625-2626.
    >> Share

  242. MAGO S, Vaziri H, Tadros M
    The Usefulness of Fecal Calprotectin in the era of the COVID-19 Pandemic.
    Gastroenterology. 2021;160:2623-2625.
    >> Share

  243. PREIDIS GA, Su GL, Morgan RL
    Reply.
    Gastroenterology. 2021;160:2633-2635.
    >> Share

  244. STANGE EF, von Bunau R, Erhardt A
    Ulcerative colitis-Maintanance of Remission With the Probiotic Escherichia coli Strain Nissle 1917.
    Gastroenterology. 2021;160:2632.
    >> Share

  245. SHMIDT E, Ho EY, Feuerstein JD, Singh S, et al
    Spotlight: Medical Management of Moderate to Severe Luminal and Perianal Fistulizing Crohn's Disease.
    Gastroenterology. 2021;160:2511.
    >> Share

  246. HO EY, Singh S, Terdiman JP
    Providing the Best Care for Patients With Crohn's Disease: An Examination of the New AGA Clinical Practice Guidelines on the Medical Management of Moderate to Severe Luminal and Perianal Fistulizing Crohn's Disease.
    Gastroenterology. 2021;160:2557-2562.
    >> Share

  247. SINGH S, Proctor D, Scott FI, Falck-Ytter Y, et al
    AGA Technical Review on the Medical Management of Moderate to Severe Luminal and Perianal Fistulizing Crohn's Disease.
    Gastroenterology. 2021;160:2512-2556.
    >> Share


  248. Medical Management of Adult Outpatients With Moderate to Severe Lunminal Crohn's Disease: Clinical Decision Support Tool.
    Gastroenterology. 2021;160:2509-2510.
    >> Share

  249. FEUERSTEIN JD, Ho EY, Shmidt E, Singh H, et al
    AGA Clinical Practice Guidelines on the Medical Management of Moderate to Severe Luminal and Perianal Fistulizing Crohn's Disease.
    Gastroenterology. 2021;160:2496-2508.
    >> Share

  250. LORZADEH A, Romero-Wolf M, Goel A, Jadhav U, et al
    Epigenetic Regulation of Intestinal Stem Cells and Disease: A Balancing Act of DNA and Histone Methylation.
    Gastroenterology. 2021;160:2267-2282.
    >> Share

  251. LI X, Liang D, Meng J, Zhou J, et al
    Development and Validation of a Novel Computed-Tomography Enterography Radiomic Approach for Characterization of Intestinal Fibrosis in Crohn's Disease.
    Gastroenterology. 2021;160:2303-2316.
    >> Share

  252. EDELMAN-KLAPPER H, Schwartz E, Ben-Horin S
    Visible Worms in a Crohn's Patient Treated with Infliximab.
    Gastroenterology. 2021;160:e10-e11.
    >> Share

    May 2021
  253. KHAN N, Mahmud N
    Effectiveness of SARS-CoV-2 vaccination in a Veterans Affairs Cohort of Inflammatory Bowel Disease Patients with Diverse Exposure to Immunosuppressive Medications.
    Gastroenterology. 2021 May 25. pii: S0016-5085(21)03066.
    >> Share

  254. PAI N, Popov J, Hill L, Hartung E, et al
    Results of the first pilot randomized controlled trial of fecal microbiota transplant in pediatric ulcerative colitis: lessons, limitations, and future prospects.
    Gastroenterology. 2021 May 4. pii: S0016-5085(21)00739.
    >> Share

  255. STALGIS C, Deepak P, Mehandru S, Colombel JF, et al
    Rational Combination Therapy to Overcome the Plateau of Drug Efficacy in Inflammatory Bowel Disease.
    Gastroenterology. 2021 May 4. pii: S0016-5085(21)00740.
    >> Share

  256. OCCHIPINTI V, Saibeni S, Sampietro GM, Pastorelli L, et al
    Impact of COVID-19 Outbreak on the Management of Patients With Severe IBD: A Domino Effect.
    Gastroenterology. 2021;160:2196-2197.
    >> Share

  257. SAHA S, Mara K, Pardi DS, Khanna S, et al
    Long-term Safety of Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection.
    Gastroenterology. 2021;160:1961-1969.
    >> Share

    April 2021
  258. AGRAWAL M, Spencer EA, Colombel JF, Ungaro RC, et al
    Approach to the management of recently diagnosed inflammatory bowel disease patients: a user's guide for adult and pediatric gastroenterologists.
    Gastroenterology. 2021 Apr 30. pii: S0016-5085(21)00734.
    >> Share

  259. RAJAMAKI K, Taira A, Katainen R, Valimaki N, et al
    Genetic and epigenetic characteristics of inflammatory bowel disease associated colorectal cancer.
    Gastroenterology. 2021 Apr 27. pii: S0016-5085(21)00680.
    >> Share

  260. AGRAWAL M, Hillenbrand CM, Allin KH, Torres J, et al
    Early life greenspace and the risk of pediatric-onset inflammatory bowel disease: insights into the link between environmental and human health.
    Gastroenterology. 2021 Apr 15. pii: S0016-5085(21)00644.
    >> Share

  261. SHEEHAN JL, Brandler J, Rice MD
    A Case of Recurrent Hepatic Abscesses.
    Gastroenterology. 2021 Apr 8. pii: S0016-5085(21)00627.
    >> Share

  262. TAXONERA C, Alba C, Olivares D
    What Is the Incidence of COVID-19 in Patients With IBD in Western Countries?
    Gastroenterology. 2021;160:1901-1902.
    >> Share

  263. MAGRO F, Dias CC, Morato M
    Aminosalicylates and COVID-19: Facts or Coincidences?
    Gastroenterology. 2021;160:1884-1885.
    >> Share

  264. RODRIGUEZ-LAGO I, Alonso-Galan H, Cabriada JL
    Cytokine Storm in IBD: Balancing the Risks of IBD Medical Therapy.
    Gastroenterology. 2021;160:1878-1880.
    >> Share

  265. RABINOWITZ LG, Kim MK, Wong SY
    Farnesoid X Receptor Variant: A Sex-based Determinant of Crohn's Disease Progression.
    Gastroenterology. 2021;160:1866-1867.
    >> Share

  266. SHORT SP, Pilat JM, Barrett CW, Reddy VK, et al
    Colonic Epithelial-Derived Selenoprotein P Is the Source for Antioxidant-Mediated Protection in Colitis-Associated Cancer.
    Gastroenterology. 2021;160:1694-1708.
    >> Share

  267. GETTLER K, Levantovsky R, Moscati A, Giri M, et al
    Common and Rare Variant Prediction and Penetrance of IBD in a Large, Multi-ethnic, Health System-based Biobank Cohort.
    Gastroenterology. 2021;160:1546-1557.
    >> Share

  268. QU JY, Li Z
    Is It a Crohn's Disease?
    Gastroenterology. 2021;160:1477-1478.
    >> Share

    March 2021
  269. SOLITANO V, Vuitton L, Peyrin-Biroulet L, Danese S, et al
    The Evolution of Biologics Administration From Intravenous to Subcutaneous: Treatments for Inflammatory Bowel Disease Goes Home.
    Gastroenterology. 2021 Mar 24. pii: S0016-5085(21)00548.
    >> Share

  270. SHIRAI T, Kakuta Y, Fujii H
    Distinct autoantibodies against endothelial protein C receptor in ulcerative colitis.
    Gastroenterology. 2021 Mar 24. pii: S0016-5085(21)00547.
    >> Share

  271. UNGER LW, Kaser A
    Is IL-6 back in trans signalling for inflammatory bowel disease?
    Gastroenterology. 2021 Mar 19. pii: S0016-5085(21)00539.
    >> Share

  272. SCHREIBER S, Ben-Horin S, Leszczyszyn J, Dudkowiak R, et al
    Randomized Controlled Trial: Subcutaneous versus Intravenous Infliximab CT-P13 Maintenance in Inflammatory Bowel Disease.
    Gastroenterology. 2021 Mar 4. pii: S0016-5085(21)00474.
    >> Share

  273. SCHREIBER S, Aden K, Bernardes JP, Conrad C, et al
    Therapeutic IL-6 trans-signalling inhibition by olamkicept (sgp130Fc) in patients with active inflammatory bowel disease.
    Gastroenterology. 2021 Mar 2. pii: S0016-5085(21)00467.
    >> Share

  274. VERMEIRE S, Hebuterne X, Tilg H, De Hertogh G, et al
    Induction and long-term follow-up with ABX464 for moderate-to-severe ulcerative colitis: Results of phase 2a trial.
    Gastroenterology. 2021 Mar 1. pii: S0016-5085(21)00459.
    >> Share

  275. ILIEV ID, Cadwell K
    Effects of Intestinal Fungi and Viruses on Immune Responses and Inflammatory Bowel Diseases.
    Gastroenterology. 2021;160:1050-1066.
    >> Share

  276. LU R, Zhang YG, Xia Y, Zhang J, et al
    Paneth Cell Alertness to Pathogens Maintained by Vitamin D Receptors.
    Gastroenterology. 2021;160:1269-1283.
    >> Share

  277. KUMAR A, Priyamvada S, Ge Y, Jayawardena D, et al
    A Novel Role of SLC26A3 in the Maintenance of Intestinal Epithelial Barrier Integrity.
    Gastroenterology. 2021;160:1240-1255.
    >> Share

  278. AL-BAHLANI AQ, Kron CM, Hart L
    Chronic Diarrhea in a Pediatric Patient after Bone Marrow Transplantation.
    Gastroenterology. 2021;160:e10-e12.
    >> Share

    February 2021
  279. BENCHIMOL EI, Tse F, Carroll MW, deBruyn JC, et al
    TEMPORARY REMOVAL: Canadian Association of Gastroenterology CLINICAL Practice Guideline For Immunizations in Patients with Inflammatory Bowel Disease (IBD). Part 2: Inactivated Vaccines.
    Gastroenterology. 2021 Feb 19. pii: S0016-5085(21)00427.
    >> Share

  280. MA C, Sedano R, Almradi A, Casteele NV, et al
    An international consensus to standardize integration of histopathology in ulcerative colitis clinical trials.
    Gastroenterology. 2021 Feb 18. pii: S0016-5085(21)00423.
    >> Share

  281. KUWADA T, Shiokawa M, Kodama Y, Ota S, et al
    Identification of an Anti-Integrin alphavbeta6 Autoantibody in Patients with Ulcerative Colitis.
    Gastroenterology. 2021 Feb 11. pii: S0016-5085(21)00406.
    >> Share

  282. COHEN RD, Feuerstein JD, Rubin DT
    REPLY to letters to the editor regarding manuscript Rubin DT, Feuerstein JD, Wang AY, Cohen RD, AGA Clinical Practice Update on Management of Inflammatory Bowel Disease During the COVID-19 Pandemic: Expert Commentary, Gastroenterology (2020).
    Gastroenterology. 2021 Feb 6. pii: S0016-5085(21)00399.
    >> Share

  283. NOWAK JK, Kalla R, Satsangi J
    SARS-CoV-2 entry molecules' expression and COVID-19 in inflammatory bowel disease: is the gut critical?
    Gastroenterology. 2021 Feb 4. pii: S0016-5085(21)00350.
    >> Share

  284. KHANNA R, Afif W
    Ustekinumab for Ulcerative colitis.
    Gastroenterology. 2021 Feb 3. pii: S0016-5085(21)00340.
    >> Share

  285. POTDAR AA, Dube S, Naito T, Li K, et al
    Altered Intestinal ACE2 Levels Are Associated With Inflammation, Severe Disease, and Response to Anti-Cytokine Therapy in Inflammatory Bowel Disease.
    Gastroenterology. 2021;160:809-822.
    >> Share

  286. TE GROEN M, Derks MEW, Kuijpers CCHJ, Nagtegaal ID, et al
    Reduction in Inflammatory Bowel Disease Healthcare During the Coronavirus Disease 2019 Pandemic: A Nationwide Retrospective Cohort Study.
    Gastroenterology. 2021;160:935-937.
    >> Share

  287. PATANKAR JV, Chiriac MT, Lehmann M, Kuhl AA, et al
    Severe Acute Respiratory Syndrome Coronavirus 2 Attachment Receptor Angiotensin-Converting Enzyme 2 Is Decreased in Crohn's Disease and Regulated By Microbial and Inflammatory Signaling.
    Gastroenterology. 2021;160:925-928.
    >> Share

  288. MELMED GY, Rubin DT, McGovern DPB
    Winter Is Coming! Clinical, Immunologic, and Practical Considerations for Vaccinating Patients With Inflammatory Bowel Disease During the Coronavirus Disease-2019 Pandemic.
    Gastroenterology. 2021;160:639-644.
    >> Share

  289. BURGUENO JF, Fritsch J, Gonzalez EE, Landau KS, et al
    Epithelial TLR4 Signaling Activates DUOX2 to Induce Microbiota-Driven Tumorigenesis.
    Gastroenterology. 2021;160:797-808.
    >> Share

  290. BARNES EL, Loftus EV Jr, Kappelman MD
    Effects of Race and Ethnicity on Diagnosis and Management of Inflammatory Bowel Diseases.
    Gastroenterology. 2021;160:677-689.
    >> Share

  291. CHUNG-YEE HUI R, Kuo KL, Yang TW
    A Rare Skin Complication Associated With Crohn's Disease.
    Gastroenterology. 2021;160:669-670.
    >> Share

  292. KUMAR A, Magro C, Lukin DJ
    Scattered Skin Eruptions in a Patient With Inflammatory Bowel Disease.
    Gastroenterology. 2021;160:e3-e5.
    >> Share

    January 2021
  293. ZILBAUER M, Heuschkel R
    Reply to Lee et al.: Analytical Mistakes Confound Attempted Validation: A Response to "Transcription and DNA Methylation Patterns of Blood-Derived CD8+ T Cells Are Associated With Age and Inflammatory Bowel Disease But Do Not Predict Prognosis".
    Gastroenterology. 2021 Jan 25. pii: S0016-5085(21)00317.
    >> Share

  294. MESERVE J, Singh S
    Pathologist, meet Picasso! Virtual chromoendoscopy for detecting histologic remission in ulcerative colitis.
    Gastroenterology. 2021 Jan 25. pii: S0016-5085(21)00318.
    >> Share

  295. TAKENAKA K, Ohtsuka K, Fujii T, Oshima S, et al
    Deep neural network accurately predicts prognosis of ulcerative colitis using endoscopic images.
    Gastroenterology. 2021 Jan 21. pii: S0016-5085(21)00278.
    >> Share

  296. RANDOLPH GJ, Czepielewski RS
    Response to: Lymphatic-dependent transport of chylomicrons in inflammatory bowel disease.
    Gastroenterology. 2021 Jan 20. pii: S0016-5085(21)00270.
    >> Share

  297. PINTO-SANCHEZ MI, Seiler C, Verdu EF
    Reply to: Inflammatory bowel disease, celiac disease, and primary sclerosing cholangitis: is there a link?
    Gastroenterology. 2021 Jan 20. pii: S0016-5085(21)00273.
    >> Share

  298. BRAND EC, Klaassen MAY, Gacesa R, Vila AV, et al
    Healthy cotwins share gut microbiome signatures with their inflammatory bowel disease twins and unrelated patients.
    Gastroenterology. 2021 Jan 18. pii: S0016-5085(21)00097.
    >> Share

  299. BHAT S, Farraye FA, Hayney MS, Caldera F, et al
    How to Implement a Successful Vaccination Program in Outpatient Gastroenterology Practices: A Focus on Patients with Inflammatory Bowel Disease and Chronic Liver Disease.
    Gastroenterology. 2021 Jan 15. pii: S0016-5085(21)00093.
    >> Share

  300. KHAN N, Yang YX
    Adherence of Infusible Biologics During the Time of COVID-19 Among Patients with Inflammatory Bowel Disease: A Nationwide Veterans Affairs Cohort Study.
    Gastroenterology. 2021 Jan 13. pii: S0016-5085(21)00071.
    >> Share

  301. LEE JC, Lyons PA, McKinney EF
    Analytical Mistakes Confound Attempted Validation: A Response to "Transcription and DNA Methylation Patterns of Blood-Derived CD8+ T Cells Are Associated With Age and Inflammatory Bowel Disease But Do Not Predict Prognosis".
    Gastroenterology. 2021 Jan 13. pii: S0016-5085(21)00081.
    >> Share

  302. LE BERRE C, Peyrin-Biroulet L
    Selecting Endpoints for Disease-Modification Trials in Inflammatory Bowel Disease: the SPIRIT consensus from the IOIBD.
    Gastroenterology. 2021 Jan 6. pii: S0016-5085(21)00016.
    >> Share

  303. CHEN E, Chuang LS, Giri M, Villaverde N, et al
    Inflamed ulcerative colitis regions associated to MRGPRX2-mediated mast cell degranulation and cell activation modules, defining a new therapeutic target.
    Gastroenterology. 2021 Jan 6. pii: S0016-5085(21)00024.
    >> Share

  304. SUAREZ-FARINAS M, Tokuyama M, Wei G, Huang R, et al
    Intestinal Inflammation Modulates the Expression of ACE2 and TMPRSS2 and Potentially Overlaps With the Pathogenesis of SARS-CoV-2-related Disease.
    Gastroenterology. 2021;160:287-301.
    >> Share

  305. LEE M, Chang EB
    Inflammatory Bowel Diseases (IBD) and the Microbiome-Searching the Crime Scene for Clues.
    Gastroenterology. 2021;160:524-537.
    >> Share

  306. KELLERMAYER R, van der Laan M
    Validation of Predictive Models in Inflammatory Bowel Diseases.
    Gastroenterology. 2021;160:21-22.
    >> Share

  307. NORSA L, D'Antiga L
    Reply.
    Gastroenterology. 2021;160:474-475.
    >> Share

  308. SAZONOVS A, Ahmad T, Anderson CA
    Underpowered PANTS: A Response to the Conclusions of "Extended Analysis Identifies Drug-Specific Association of Two Distinct HLA Class II Haplotypes for Development of Immunogenicity to Adalimumab and Infliximab".
    Gastroenterology. 2021;160:470-471.
    >> Share

  309. CASADEI C, Barberio B, Savarino E
    A Peculiar Cutaneous Manifestation in a Patient With Crohn's Disease.
    Gastroenterology. 2021;160:e1-e3.
    >> Share

  310. ZHANG J, Hoedt EC, Liu Q, Berendsen E, et al
    Elucidation of Proteus mirabilis as a Key Bacterium in Crohn's Disease Inflammation.
    Gastroenterology. 2021;160:317-330.
    >> Share

  311. RICCIUTO A, Aardoom M, Orlanski-Meyer E, Navon D, et al
    Predicting Outcomes in Pediatric Crohn's Disease for Management Optimization: Systematic Review and Consensus Statements From the Pediatric Inflammatory Bowel Disease-Ahead Program.
    Gastroenterology. 2021;160:403-436.
    >> Share

    December 2020
  312. UNGARO RC, Kappelman MD, Rubin DT, Colombel JF, et al
    COVID-19 and Inflammatory Bowel Disease: Lessons Learned, Practical Recommendations, and Unanswered Questions.
    Gastroenterology. 2020 Dec 30. pii: S0016-5085(20)35600.
    >> Share

  313. TIAN Y, Zuo L
    Lymphatic-dependent transport of chylomicrons in inflammatory bowel disease.
    Gastroenterology. 2020 Dec 29. pii: S0016-5085(20)35599.
    >> Share

  314. TSE CS, Deepak P, Papadakis K
    Inflammatory bowel disease, celiac disease, and primary sclerosing cholangitis: is there a link?
    Gastroenterology. 2020 Dec 29. pii: S0016-5085(20)35594.
    >> Share

  315. WIJNANDS AM, de Jong ME, Lutgens MWMD, Hoentjen F, et al
    Prognostic factors for advanced colorectal neoplasia in inflammatory bowel disease: systematic review and meta-analysis.
    Gastroenterology. 2020 Dec 29. pii: S0016-5085(20)35587.
    >> Share

  316. SHIMIZU MS, Matsuo T, Mori N
    A rare manifestation associated with a urinary tract infection in a patient with ulcerative colitis.
    Gastroenterology. 2020 Dec 21. pii: S0016-5085(20)35566.
    >> Share

  317. TURNER D, Ricciuto A, Lewis A, D'Amico F, et al
    STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD.
    Gastroenterology. 2020 Dec 21. pii: S0016-5085(20)35572.
    >> Share

  318. DEVLIN JC, Axelrad J, Hine AM, Chang S, et al
    Single Cell Transcriptional Survey of Ileal-Anal Pouch Immune Cells from Ulcerative Colitis Patients.
    Gastroenterology. 2020 Dec 21. pii: S0016-5085(20)35571.
    >> Share

  319. IACUCCI M, Smith SC, Bazarova A, Shivaji UN, et al
    An international multicenter real-life prospective study of electronic chromoendoscopy score PICaSSO in Ulcerative Colitis.
    Gastroenterology. 2020 Dec 18. pii: S0016-5085(20)35563.
    >> Share

  320. WAUTERS L, Ceulemans M, Frings D, Lambaerts M, et al
    Proton pump inhibitors reduce duodenal eosinophilia, mast cells and permeability in patients with functional dyspepsia.
    Gastroenterology. 2020 Dec 17. pii: S0016-5085(20)35552.
    >> Share

  321. KIM ES, Tarassishin L, Eisele C, Barre A, et al
    Longitudinal Changes in Fecal Calprotectin Levels among Pregnant Women with and without Inflammatory Bowel Disease and Their Babies.
    Gastroenterology. 2020 Dec 8. pii: S0016-5085(20)35532.
    >> Share

  322. VERSTOCKT B, Torres J
    Point-of-care intestinal ultrasound: prime time for the management of ulcerative colitis?
    Gastroenterology. 2020 Dec 8. pii: S0016-5085(20)35541.
    >> Share

  323. GALIPEAU HJ, Caminero A, Turpin W, Bermudez-Brito M, et al
    Novel fecal biomarkers that precede clinical diagnosis of ulcerative colitis.
    Gastroenterology. 2020 Dec 8. pii: S0016-5085(20)35533.
    >> Share

  324. ROSEN MJ
    Could a Small Population of Epithelial Cells Get "Tuft" With Crohn's Disease?
    Gastroenterology. 2020;159:2025-2027.
    >> Share

  325. KONG L, Lloyd-Price J, Vatanen T, Seksik P, et al
    Linking Strain Engraftment in Fecal Microbiota Transplantation With Maintenance of Remission in Crohn's Disease.
    Gastroenterology. 2020;159:2193-2202.
    >> Share

  326. BANERJEE A, Herring CA, Chen B, Kim H, et al
    Succinate Produced by Intestinal Microbes Promotes Specification of Tuft Cells to Suppress Ileal Inflammation.
    Gastroenterology. 2020;159:2101-2115.
    >> Share

  327. TURPIN W, Lee SH, Raygoza Garay JA, Madsen KL, et al
    Increased Intestinal Permeability Is Associated With Later Development of Crohn's Disease.
    Gastroenterology. 2020;159:2092-2100.
    >> Share

  328. COURTET A, Lemale J, Carra MC
    Generalized Gingival Hyperplasia and Rectorrhagia in a 13-Year-Old Boy.
    Gastroenterology. 2020;159:2030-2033.
    >> Share

  329. ANGELINO G, Francalanci P, Tambucci R
    Terminal Ileum Thickening and Mucosal Ulcers in a Boy With Neurofibromatosis Type 1.
    Gastroenterology. 2020;159:e9-e11.
    >> Share

    November 2020
  330. MAHADEVAN U, Long MD, Kane SV, Roy A, et al
    Pregnancy and Neonatal Outcomes after Fetal Exposure To Biologics and Thiopurines among Women with Inflammatory Bowel Disease.
    Gastroenterology. 2020 Nov 20. pii: S0016-5085(20)35441.
    >> Share

  331. TAXONERA C, Fisac J, Alba C
    Can COVID-19 trigger de novo inflammatory bowel disease?
    Gastroenterology. 2020 Nov 19. pii: S0016-5085(20)35424.
    >> Share

  332. FAIRBRASS KM, Gracie DJ, Ford AC
    In the Face of Adversity: Is Resilience Training a New Target for Inflammatory Bowel Disease Therapy?
    Gastroenterology. 2020 Nov 19. pii: S0016-5085(20)35417.
    >> Share

  333. TORRES J, Riddle M, Colombel JF
    Answer to the letter by Rodriguez-Lago et al: Pre-inflammatory bowel disease: back to the future.
    Gastroenterology. 2020 Nov 4. pii: S0016-5085(20)35363.
    >> Share

  334. KOCHAR B, Ananthakrishnan AN
    Reply.
    Gastroenterology. 2020;159:1993-1994.
    >> Share

  335. ALLEGRETTI JR, Kelly CR, Grinspan A, Mullish BH, et al
    Outcomes of Fecal Microbiota Transplantation in Patients With Inflammatory Bowel Diseases and Recurrent Clostridioides difficile Infection.
    Gastroenterology. 2020;159:1982-1984.
    >> Share

  336. PARLATO M, Nian Q, Charbit-Henrion F, Ruemmele FM, et al
    Loss-of-Function Mutation in PTPN2 Causes Aberrant Activation of JAK Signaling Via STAT and Very Early Onset Intestinal Inflammation.
    Gastroenterology. 2020;159:1968-1971.
    >> Share

  337. HUANG LH, Deepak P, Ciorba MA, Mittendorfer B, et al
    Postprandial Chylomicron Output and Transport Through Intestinal Lymphatics Are Not Impaired in Active Crohn's Disease.
    Gastroenterology. 2020;159:1955-1957.
    >> Share

  338. SPALINGER MR, Sayoc-Becerra A, Santos AN, Shawki A, et al
    PTPN2 Regulates Interactions Between Macrophages and Intestinal Epithelial Cells to Promote Intestinal Barrier Function.
    Gastroenterology. 2020;159:1763-1777.
    >> Share

    October 2020
  339. NAITO T, Botwin GJ, Haritunians T, Li D, et al
    Prevalence and Effect of Genetic Risk of Thrombo-embolic Disease in Inflammatory Bowel Disease.
    Gastroenterology. 2020 Oct 19. pii: S0016-5085(20)35276.
    >> Share

  340. GOTTLIEB K, Requa J, Karnes W, Chandra Gudivada R, et al
    Central reading of ulcerative colitis clinical trial videos using neural networks.
    Gastroenterology. 2020 Oct 17. pii: S0016-5085(20)35283.
    >> Share

  341. BOSSUYT P, De Hertogh G, Eelbode T, Vermeire S, et al
    Computer aided diagnosis with monochromatic light endoscopy for scoring histological remission in ulcerative colitis.
    Gastroenterology. 2020 Oct 12. pii: S0016-5085(20)35246.
    >> Share

  342. ANANTHAKRISHNAN AN, Nguyen GC, Bernstein CN
    AGA Clinical Practice Update on Management of Inflammatory Bowel Disease in the Elderly: Expert Review.
    Gastroenterology. 2020 Oct 1. pii: S0016-5085(20)35219.
    >> Share

  343. GARG M, Christensen B, Lubel JS
    Gastrointestinal ACE2, COVID-19 and IBD: Opportunity in the Face of Tragedy?
    Gastroenterology. 2020;159:1623-1624.
    >> Share

  344. PARIGI TL, Bonifacio C, Danese S
    Is It Crohn's Disease?
    Gastroenterology. 2020;159:1244-1246.
    >> Share

  345. TAKENAKA K, Ohtsuka K, Suzuki K, Watanabe M, et al
    Reply.
    Gastroenterology. 2020;159:1626-1627.
    >> Share

  346. GORDON M, Guyatt G
    Assessment of Evidence Quality in Inflammatory Bowel Disease Guidance: The Use and Misuse of GRADE.
    Gastroenterology. 2020;159:1209-1215.
    >> Share

  347. STENGEL ST, Fazio A, Lipinski S, Jahn MT, et al
    Activating Transcription Factor 6 Mediates Inflammatory Signals in Intestinal Epithelial Cells Upon Endoplasmic Reticulum Stress.
    Gastroenterology. 2020;159:1357-1374.
    >> Share

  348. RAWAT M, Nighot M, Al-Sadi R, Gupta Y, et al
    IL1B Increases Intestinal Tight Junction Permeability by Up-regulation of MIR200C-3p, Which Degrades Occludin mRNA.
    Gastroenterology. 2020;159:1375-1389.
    >> Share

    September 2020
  349. KELLY CR, Yen EF, Grinspan AM, Kahn SA, et al
    Fecal Microbiota Transplant is Highly Effective in Real-World Practice: Initial Results from the FMT National Registry.
    Gastroenterology. 2020 Sep 30. pii: S0016-5085(20)35221.
    >> Share

  350. MEYER EO, Aardoom M, Ricciuto A, Navon D, et al
    Predicting Outcomes in Pediatric Ulcerative Colitis for Management Optimization: Systematic Review and Consensus Statements from PIBD-Ahead Program.
    Gastroenterology. 2020 Sep 22. pii: S0016-5085(20)35206.
    >> Share

  351. PAUL S, Roblin X
    The Nightmare Monitoring of JAKinhibs.
    Gastroenterology. 2020;159:1188-1189.
    >> Share

  352. TILG H, D'Haens G
    How to Manage Crohn's Disease After Ileocolonic Resection?
    Gastroenterology. 2020;159:816-820.
    >> Share

  353. KANG JW, Yan J, Ranjan K, Zhang X, et al
    Myeloid Cell Expression of LACC1 Is Required for Bacterial Clearance and Control of Intestinal Inflammation.
    Gastroenterology. 2020;159:1051-1067.
    >> Share

  354. KREISS L, Thoma OM, Dilipkumar A, Carle B, et al
    Label-Free In Vivo Histopathology of Experimental Colitis via 3-Channel Multiphoton Endomicroscopy.
    Gastroenterology. 2020;159:832-834.
    >> Share

  355. HALL CHT, Lee JS, Murphy EM, Gerich ME, et al
    Creatine Transporter, Reduced in Colon Tissues From Patients With Inflammatory Bowel Diseases, Regulates Energy Balance in Intestinal Epithelial Cells, Epithelial Integrity, and Barrier Function.
    Gastroenterology. 2020;159:984-998.
    >> Share

  356. PINTO-SANCHEZ MI, Seiler CL, Santesso N, Alaedini A, et al
    Association Between Inflammatory Bowel Diseases and Celiac Disease: A Systematic Review and Meta-Analysis.
    Gastroenterology. 2020;159:884-903.
    >> Share

    August 2020
  357. STAHL E, Roda G, Dobbyn A, Hu J, et al
    Collagenous Colitis Is Associated With HLA Signature and Shares Genetic Risks With Other Immune-Mediated Diseases.
    Gastroenterology. 2020;159:549-561.
    >> Share

  358. POWELL DOHERTY RD, Liao H, Satsangi JJ, Ternette N, et al
    Extended Analysis Identifies Drug-Specific Association of 2 Distinct HLA Class II Haplotypes for Development of Immunogenicity to Adalimumab and Infliximab.
    Gastroenterology. 2020;159:784-787.
    >> Share

  359. APOSTOLOV R, Tan N, Vasudevan A
    Poor Bowel Preparation in Crohn's Disease.
    Gastroenterology. 2020;159:440-442.
    >> Share

    July 2020
  360. BERNSTEIN CN
    New Biomarkers for Crohn's Disease.
    Gastroenterology. 2020;159:30-32.
    >> Share

  361. UNO Y
    Why a Low FODMAP Diet Was Ineffective for IBS Symptoms in Quiescent Crohn's Disease.
    Gastroenterology. 2020;159:399.
    >> Share

  362. ARDALAN ZS, Sparrow M, Gibson PR
    The Importance of Accurate Phenotyping and Pouchitis Risk and Dietary Assessment When Investigating the Microbial Factors Behind Antibiotic-Dependent Pouchitis.
    Gastroenterology. 2020;159:399-400.
    >> Share

  363. PICKERT G, Wirtz S, Matzner J, Ashfaq-Khan M, et al
    Wheat Consumption Aggravates Colitis in Mice via Amylase Trypsin Inhibitor-mediated Dysbiosis.
    Gastroenterology. 2020;159:257-272.
    >> Share

  364. EL-MATARY W, Nugent Z, Bernstein CN, Singh H, et al
    Long-term Cancer Risk in Patients With Pediatric-Onset Inflammatory Bowel Diseases in the Canadian Population.
    Gastroenterology. 2020;159:386-387.
    >> Share

  365. NAIR N, Austin C, Curtin P, Gouveia C, et al
    Association Between Early-life Exposures and Inflammatory Bowel Diseases, Based on Analyses of Deciduous Teeth.
    Gastroenterology. 2020;159:383-385.
    >> Share

  366. UNGARO RC, Yzet C, Bossuyt P, Baert FJ, et al
    Deep Remission at 1 Year Prevents Progression of Early Crohn's Disease.
    Gastroenterology. 2020;159:139-147.
    >> Share

  367. MULLIN GE, Chey WD, Crowe SE
    The 2019 James W. Freston Conference: Food at the Intersection of Gut Health and Disease.
    Gastroenterology. 2020;159:20-25.
    >> Share

  368. HEALY ME, Boege Y, Hodder MC, Bohm F, et al
    MCL1 Is Required for Maintenance of Intestinal Homeostasis and Prevention of Carcinogenesis in Mice.
    Gastroenterology. 2020;159:183-199.
    >> Share

  369. TORRES J, Petralia F, Sato T, Wang P, et al
    Serum Biomarkers Identify Patients Who Will Develop Inflammatory Bowel Diseases Up to 5 Years Before Diagnosis.
    Gastroenterology. 2020;159:96-104.
    >> Share

    June 2020
  370. SABINO J, Torres J
    You Are What You Eat, But Can Diet Prevent Inflammatory Bowel Diseases?
    Gastroenterology. 2020;158:2304-2305.
    >> Share

  371. ZIDAR N
    Histopathology of Fibrosis in Crohn's Disease: The Importance of Understanding Its Pathogenesis.
    Gastroenterology. 2020;158:2313-2314.
    >> Share

  372. BOUHNIK Y, Louis E, Peyrin-Biroulet L
    Looking for Innovative Digital Solutions to Optimize Patient Recruitment in Inflammatory Bowel Disease Trials.
    Gastroenterology. 2020;158:2306-2307.
    >> Share

  373. KOLLEN L, Werner O, Gavotto A
    Uncommon Cause of Chest Pain in a 9-Year-Old Boy With Crohn's Disease.
    Gastroenterology. 2020;158:2055-2057.
    >> Share

  374. KOCHAR B, Cai W, Cagan A, Ananthakrishnan AN, et al
    Pretreatment Frailty Is Independently Associated With Increased Risk of Infections After Immunosuppression in Patients With Inflammatory Bowel Diseases.
    Gastroenterology. 2020;158:2104-2111.
    >> Share

  375. CROWLEY E, Warner N, Pan J, Khalouei S, et al
    Prevalence and Clinical Features of Inflammatory Bowel Diseases Associated With Monogenic Variants, Identified by Whole-Exome Sequencing in 1000 Children at a Single Center.
    Gastroenterology. 2020;158:2208-2220.
    >> Share

  376. SANDBORN WJ, Feagan BG, Loftus EV Jr, Peyrin-Biroulet L, et al
    Efficacy and Safety of Upadacitinib in a Randomized Trial of Patients With Crohn's Disease.
    Gastroenterology. 2020;158:2123-2138.
    >> Share

  377. LOEBENSTEIN M, Schulberg JD
    Anti-TNF Rechallenge After Infliximab Induced Lupus in Crohn's Disease.
    Gastroenterology. 2020;158:2069-2071.
    >> Share

    May 2020
  378. TRIVEDI PJ, Crothers H, Mytton J, Bosch S, et al
    Effects of Primary Sclerosing Cholangitis on Risks of Cancer and Death in People With Inflammatory Bowel Diseases, Based on Sex, Race, and Age.
    Gastroenterology. 2020 May 20. pii: S0016-5085(20)34702.
    >> Share

  379. OLIVERA PA, Lasa JS, Bonovas S, Danese S, et al
    Safety of Janus Kinase Inhibitors in Patients With Inflammatory Bowel Diseases or Other Immune-mediated Diseases: A Systematic Review and Meta-Analysis.
    Gastroenterology. 2020;158:1554-1573.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016